The TGF-β1/p53/PAI-1 Signaling Axis in Vascular Senescence: Role of Caveolin-1
Stress-induced premature cellular senescence is a significant factor in the onset of age-dependent disease in the cardiovascular system. Plasminogen activator inhibitor-1 (PAI-1), a major TGF-β1/p53 target gene and negative regulator of the plasmin-based pericellular proteolytic cascade, is...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/9/8/341 |
id |
doaj-76f69ca8e02f4dec82f7251a97ad9bee |
---|---|
record_format |
Article |
spelling |
doaj-76f69ca8e02f4dec82f7251a97ad9bee2020-11-25T01:17:11ZengMDPI AGBiomolecules2218-273X2019-08-019834110.3390/biom9080341biom9080341The TGF-β1/p53/PAI-1 Signaling Axis in Vascular Senescence: Role of Caveolin-1Rohan Samarakoon0Stephen P. Higgins1Craig E. Higgins2Paul J. Higgins3Department of Regenerative & Cancer Cell Biology, Albany Medical College, Albany, NY 12208, USADepartment of Regenerative & Cancer Cell Biology, Albany Medical College, Albany, NY 12208, USADepartment of Regenerative & Cancer Cell Biology, Albany Medical College, Albany, NY 12208, USADepartment of Regenerative & Cancer Cell Biology, Albany Medical College, Albany, NY 12208, USAStress-induced premature cellular senescence is a significant factor in the onset of age-dependent disease in the cardiovascular system. Plasminogen activator inhibitor-1 (PAI-1), a major TGF-β1/p53 target gene and negative regulator of the plasmin-based pericellular proteolytic cascade, is elevated in arterial plaques, vessel fibrosis, arteriosclerosis, and thrombosis, correlating with increased tissue TGF-β1 levels. Additionally, PAI-1 is necessary and sufficient for the induction of p53-dependent replicative senescence. The mechanism of PAI-1 transcription in senescent cells appears to be dependent on caveolin-1 signaling. <i>Src</i> kinases are upstream effectors of both FAK and caveolin-1 activation as FAK<sup>Y577,Y861</sup> and caveolin-1<sup>Y14</sup> phosphorylation are not detected in TGF-β1-stimulated <i>src</i> family kinase (pp60<sup>c-<i>src</i></sup>, Yes, Fyn) triple-deficient (SYF<sup>−/−/−</sup>) cells. However, restoration of pp60<sup>c-src</sup> expression in SYF-null cells rescued both caveolin-1<sup>Y14</sup> phosphorylation and PAI-1 induction in response to TGF-β1. Furthermore, TGF-β1-initiated <i>Src</i> phosphorylation of caveolin-1<sup>Y14</sup> is critical in Rho-ROCK-mediated suppression of the SMAD phosphatase PPM1A maintaining and, accordingly, SMAD2/3-dependent transcription of the PAI-1 gene. Importantly, TGF-β1 failed to induce PAI-1 expression in caveolin-1-null cells, correlating with reductions in both Rho-GTP loading and SMAD2/3 phosphorylation. These findings implicate caveolin-1 in expression controls on specific TGF-β1/p53 responsive growth arrest genes. Indeed, up-regulation of caveolin-1 appears to stall cells in G<sub>0</sub>/G<sub>1</sub> via activation of the p53/p21 cell cycle arrest pathway and restoration of caveolin-1 in caveolin-1-deficient cells rescues TGF-β1 inducibility of the PAI-1 gene. Although the mechanism is unclear, caveolin-1 inhibits p53/MDM2 complex formation resulting in p53 stabilization, induction of p53-target cell cycle arrest genes (including PAI-1), and entrance into premature senescence while stimulating the ATM→p53→p21 pathway. Identification of molecular events underlying senescence-associated PAI-1 expression in response to TGF-β1/<i>src</i> kinase/p53 signaling may provide novel targets for the therapy of cardiovascular disease.https://www.mdpi.com/2218-273X/9/8/341vascular diseasesenescencep53TGF-β1plasminogen activator inhibitor-1 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Rohan Samarakoon Stephen P. Higgins Craig E. Higgins Paul J. Higgins |
spellingShingle |
Rohan Samarakoon Stephen P. Higgins Craig E. Higgins Paul J. Higgins The TGF-β1/p53/PAI-1 Signaling Axis in Vascular Senescence: Role of Caveolin-1 Biomolecules vascular disease senescence p53 TGF-β1 plasminogen activator inhibitor-1 |
author_facet |
Rohan Samarakoon Stephen P. Higgins Craig E. Higgins Paul J. Higgins |
author_sort |
Rohan Samarakoon |
title |
The TGF-β1/p53/PAI-1 Signaling Axis in Vascular Senescence: Role of Caveolin-1 |
title_short |
The TGF-β1/p53/PAI-1 Signaling Axis in Vascular Senescence: Role of Caveolin-1 |
title_full |
The TGF-β1/p53/PAI-1 Signaling Axis in Vascular Senescence: Role of Caveolin-1 |
title_fullStr |
The TGF-β1/p53/PAI-1 Signaling Axis in Vascular Senescence: Role of Caveolin-1 |
title_full_unstemmed |
The TGF-β1/p53/PAI-1 Signaling Axis in Vascular Senescence: Role of Caveolin-1 |
title_sort |
tgf-β1/p53/pai-1 signaling axis in vascular senescence: role of caveolin-1 |
publisher |
MDPI AG |
series |
Biomolecules |
issn |
2218-273X |
publishDate |
2019-08-01 |
description |
Stress-induced premature cellular senescence is a significant factor in the onset of age-dependent disease in the cardiovascular system. Plasminogen activator inhibitor-1 (PAI-1), a major TGF-β1/p53 target gene and negative regulator of the plasmin-based pericellular proteolytic cascade, is elevated in arterial plaques, vessel fibrosis, arteriosclerosis, and thrombosis, correlating with increased tissue TGF-β1 levels. Additionally, PAI-1 is necessary and sufficient for the induction of p53-dependent replicative senescence. The mechanism of PAI-1 transcription in senescent cells appears to be dependent on caveolin-1 signaling. <i>Src</i> kinases are upstream effectors of both FAK and caveolin-1 activation as FAK<sup>Y577,Y861</sup> and caveolin-1<sup>Y14</sup> phosphorylation are not detected in TGF-β1-stimulated <i>src</i> family kinase (pp60<sup>c-<i>src</i></sup>, Yes, Fyn) triple-deficient (SYF<sup>−/−/−</sup>) cells. However, restoration of pp60<sup>c-src</sup> expression in SYF-null cells rescued both caveolin-1<sup>Y14</sup> phosphorylation and PAI-1 induction in response to TGF-β1. Furthermore, TGF-β1-initiated <i>Src</i> phosphorylation of caveolin-1<sup>Y14</sup> is critical in Rho-ROCK-mediated suppression of the SMAD phosphatase PPM1A maintaining and, accordingly, SMAD2/3-dependent transcription of the PAI-1 gene. Importantly, TGF-β1 failed to induce PAI-1 expression in caveolin-1-null cells, correlating with reductions in both Rho-GTP loading and SMAD2/3 phosphorylation. These findings implicate caveolin-1 in expression controls on specific TGF-β1/p53 responsive growth arrest genes. Indeed, up-regulation of caveolin-1 appears to stall cells in G<sub>0</sub>/G<sub>1</sub> via activation of the p53/p21 cell cycle arrest pathway and restoration of caveolin-1 in caveolin-1-deficient cells rescues TGF-β1 inducibility of the PAI-1 gene. Although the mechanism is unclear, caveolin-1 inhibits p53/MDM2 complex formation resulting in p53 stabilization, induction of p53-target cell cycle arrest genes (including PAI-1), and entrance into premature senescence while stimulating the ATM→p53→p21 pathway. Identification of molecular events underlying senescence-associated PAI-1 expression in response to TGF-β1/<i>src</i> kinase/p53 signaling may provide novel targets for the therapy of cardiovascular disease. |
topic |
vascular disease senescence p53 TGF-β1 plasminogen activator inhibitor-1 |
url |
https://www.mdpi.com/2218-273X/9/8/341 |
work_keys_str_mv |
AT rohansamarakoon thetgfb1p53pai1signalingaxisinvascularsenescenceroleofcaveolin1 AT stephenphiggins thetgfb1p53pai1signalingaxisinvascularsenescenceroleofcaveolin1 AT craigehiggins thetgfb1p53pai1signalingaxisinvascularsenescenceroleofcaveolin1 AT pauljhiggins thetgfb1p53pai1signalingaxisinvascularsenescenceroleofcaveolin1 AT rohansamarakoon tgfb1p53pai1signalingaxisinvascularsenescenceroleofcaveolin1 AT stephenphiggins tgfb1p53pai1signalingaxisinvascularsenescenceroleofcaveolin1 AT craigehiggins tgfb1p53pai1signalingaxisinvascularsenescenceroleofcaveolin1 AT pauljhiggins tgfb1p53pai1signalingaxisinvascularsenescenceroleofcaveolin1 |
_version_ |
1725147513632063488 |